HomeBUSINESS
BUSINESS

Ethical Drug Sales Up 0.7% in September; 1st DPP-4/SGLT2 Combo Upbeat: Crecon
(Nov.10.2017)

Ethical drug sales in Japan crept up 0.7% in September compared to the same month in the previous year, with the country’s first DPP-4/SGLT-2 inhibitor combo med Canalia (teneligliptin + canagliflozin) showing strengths, according to a flash report released by Crecon Research & Consulting ...
(LOG IN FOR FULL STORY)

News Calendar